Abstract
Human embryonic stem cells (HESC) are pluripotent stem cells isolated from the inner cell mass of human blastocysts. With the first successful culturing of HESC, a new era of regenerative medicine was born. HESC can differentiate into almost any cell type and, in the future, might replace solid organ transplantation and even be used to treat progressive degenerative diseases such as Parkinson’s disease. Although this sounds promising, certain obstacles remain with regard to their clinical use, such as culturing HESC under well-defined conditions without exposure to animal proteins, the risk of teratoma development and finally the avoidance of immune rejection. In this review, we discuss the immunological properties of HESC and various strategic solutions to circumvent immune rejection, such as stem cell banking, somatic cell nuclear transfer and the induction of tolerance by co-stimulation blockade and mixed chimerism.
Similar content being viewed by others
References
Anderson D, Billingham RE, Lampkin GH, Medawar PB (1951) The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 5:379–397
Becker YT, Becker BN, Pirsch JD, Sollinger HW (2004) Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 4:996–1001
Billingham RE, Lampkin GH, Medawar PB, Williams HLI (1952) Tolerance to homografts, twin diagnosis and the freemartin condition in cattle. Heredity 6:201–212
Bonde S, Zavazava N (2006) Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24:2192–2201
Bradley JA, Bolton EM, Pedersen RA (2002) Stem cell medicine encounters the immune system. Nat Rev Immunol 2:859–871
Burt RK, Verda L, Kim DA, Oyama Y, Luo K, Link C (2004) Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J Exp Med 199:895–904
Caballero A, Fernandez N, Lavado R, Bravo MJ, Miranda JM, Alonso A (2006) Tolerogenic response: allorecognition pathways. Transpl Immunol 17:3–6
Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS (2001) Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172:383–397
Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A, Bhatia M (2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:906–915
Cibelli JB, Campbell KH, Seidel GE, West MD, Lanza RP (2002) The health profile of cloned animals. Nat Biotechnol 20:13–14
Clausen H, Hakomori S (1989) ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 56:1–20
Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F (1998) Rituximab for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 92:1927
Cooper DK (1990) Clinical survey of heart transplantation between ABO blood-group-incompatible recipients and donors. J Heart Transplant 9:376–381
Corbascio M, Mahanty H, Osterholm C, Qi Z, Pearson TC, Larsen CP, Freise CE, Ekberg H (2002) Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. Transplantation 74:35–41
Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99:9864–9869
Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N (2006) Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24:221–229
Ellerstrom C, Strehl R, Moya K, Andersson K, Bergh C, Lundin K, Hyllner J, Semb H (2006) Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24:2170–2176
Elwood ET, Larsen CP, Cho HR, Corbascio M, Ritchie SC, Alexander DZ, Tucker-Burden C, Linsley PS, Aruffo A, Hollenbaugh D, Winn KJ, Pearson TC (1998) Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 65:1422–1428
Fairchild PJ (1998) Presentation of antigenic peptides by products of the major histocompatibility complex. J Peptide Sci 4:182–194
Fändrich F, Lin X, Chai GX, Schulze M, Ganten D, Bader M, Holle J, Huang DS, Parwaresch R, Zavazava N, Binas B (2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171–178
Frasca L, Marelli-Berg F, Imami N, Potolicchio I, Carmichael P, Lombardi G, Lechler R (1998) Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 53:679–689
Genberg H, Hansson A, Wernerson A, Wennberg L, Tydén G (2006) Pharmacodynamics of Rituximab in kidney allotransplantation.Am J Transplant 6:2418–2428
Grinnemo KH, Kumagai-Braesch M, Månsson-Broberg A, Skottman H, Hao X, Siddiqui A, Andersson A, Strömberg AM, Lahesmaa R, Hovatta O, Sylven C, Corbascio M, Dellgren G (2006) Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 13:712–724
Hovatta O, Mikkola M, Gertow K, Stromberg AM, Inzunza J, Hreinsson J, Rozell B, Blennow E, Andang M, Ahrlund-Richter L (2003) A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 18:1404–1409
Ilstad ST, Sachs DH (1984) Reconstitution with syngeneic and allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168–170
Ilstad ST, Wren S, Bluestone JA, Barbieri SA, Sachs DH (1985) Characterisation of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med 162:231–244
Inzunza J, Gertow K, Stromberg AM, Matilainen E, Blennow E, Skottman H, Wolbank S, Ahrlund-Richter L, Hovatta O (2005) Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23:544–549
Itescu S, Tung TC, Burke EM, Weinberg A, Moazami N, Artrip JH, Suciu-Foca N, Rose EA, Oz MC, Michler RE (1998) Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98:786–793
Ito N, Hirota T (1992) Histochemical and cytochemical localisation of blood-group antigens. Prog Histochem Cytochem 25:1–85
Janeway CA Jr (1999) The role of self-recognition in receptor repertoire development. Members of the Janeway laboratory. Immunol Res 19:107–118
Janeway CA Jr, Ron J, Katz ME (1987) The B cell is the initiating antigen presenting cell in peripheral lymph nodes. J Immunol 138:1051–1055
Johnson MA, Weick JP, Pearce RA, Zhang SC (2007) Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci 27:3069–3077
Kaech SM, Wherry EJ, Ahmed R (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2:251–262
Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716–10721
Kennedy D (2006) Editorial retraction (Letter). Science 311:335
Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R (2005) Human embryonic stem cells derived without feeder cells. Lancet 365:1636–1641
Koivisto H, Hyvarinen M, Stromberg AM, Inzunza J, Matilainen E, Mikkola M, Hovatta O, Teerijoki H (2004) Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reprod Biomed Online 9:330–337
Kumagai-Braesch M, Ekberg J, Holgersson J, Corbascio M (2007) Anti-LFA-1 improves pig islet function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L. Transplantation (in press)
Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434–438
Larsson LC, Corbascio M, Pearson TC, Larsen CP, Ekberg H, Widner H (2003) Induction of operational tolerance to discordant dopaminergic porcine xenografts. Transplantation 75:1448–1454
Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R (2002) Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391–4396
Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J, Bhatia M (2004) Human embryonic stem cells possess immune-privileged properties. Stem Cells 22:448–456
Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA (2006) Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185–187
Magliocca JF, Held IKA, Odorico JS (2006) Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 15:707–717
Maloney D, Liles T, Czerwinski D, Waldichuk C, Rosenberg J, Grillo-Lopez A, Levy R (1994) Phase I clinical trial using escalating single dose infusion of chimeric anti-CD20 monoclonal antibody in patients with recurrent B-cell lymphoma. Blood 84:2457
Martin MJ, Muotri A, Gage F, Varki A (2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11:228–232
Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, Brink S van den, Hassink R, Heyden M van der, Opthof T, Pera M, Riviere AB de la, Passier R, Tertoolen L (2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107:2733–2740
Nadler LM, Ritz J, Hardy R, Pesando JM, Schlossman SF, Stashenko P (1981) A unique cell surface antigen identifying lymphoid malignancies of B-cell origin. J Clin Invest 67:134
Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J (1999) HLA compatibility and organ transplant survival. Collaborant transplant study. Rev Immunogenet 1:334–342
Owen RD (1945) Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400–401
Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735–739
Paul LC, Baldwin WM (1987) Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transplant Proc 19:4463–4467
Penn I (2000) Post-transplant malignancy: the role of immunosuppression. Drug Safety 23:101–113
Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, Martin PJ, Hansen JA (1997) Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89:1818–1823
Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Michelson EM, Woolfrey AE, Hansen JA (1998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92:3515–3520
Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK (2003) Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 12:1–11
Rasetter W, Molina A, White CA (2004) Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 55:477–503
Rathjen J, Rathjen PD (2001) Mouse ES cells: experimental exploitation of pluripotent differentiation potential. Curr Opin Genet Dev 11:587–594
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399–404
Reubinoff BE, Itsykson P, Tyretski T, Pera MF, Reinhartz E, Itzik A, Ben-Hur T (2001) Neural progenitors from human embryonic stem cells. Nat Biotechnol 19:1134–1140
Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD (2007) Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918–928
Rogers NJ, Lechler RI (2001) Allorecognition. Am J Transplant 1:97–102
Schulz T, Palmarini GM, Noggle SA, Weiler DA, Mitalipova MM, Condie BG (2003) Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci 22:27
Sharabi Y, Sachs DH (1989) Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 169:493–502
Simon DM, Levin S (2001) Infectious complications of solid organ transplantations. Infect Dis Clin North Am 15:521–549
Simpson E, Scott D, James E, Lombardi G, Cwynarski K, Dazzi F, Millrain JM, Dyson PJ (2001) Minor H antigens: genes and peptides. Eur J Immunogenet 28:505–513
Snell GD (1964) Methods for study of histocompatibility genes and isoantigens. Methods Med Res 10:1–7
Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King KE, Shirey RS, Simpkins CE, Montgomery RA (2004) Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4:1316–1322
Stojkovic P, Lako M, Przyborski S, Stewart R, Armstrong L, Evans J, Zhang X, Stojkovic M (2005) Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 23:895–902
Taylor DO, Edwards LB, Boucek MM, Trulock EP, Waltz DA, Kech BM, Hertz MI (2006) Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report–2006. J Heart Lung Transplant 25:869–879
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Tomita Y, Sachs DH, Khan A, Sykes M (1996) Additional mAb injections can replace thymic irradiation to allow induction of chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T-cell mAbs and 3 Gy whole body irradiation. Transplantation 61:469–477
Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, Ha J, Durham MM, Corbascio M, Cowan SR, Pearson TC, Larsen CP (1999) Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 104:1715–1722
Tsokos GC (2004) B-cells, be gone—B-cell depletion in the treatment of reumatoid arthritis. N Eng J Med 350:2546–2548
Tydén G, Kumlien G, Fehrman I (2003) Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoabsorption and Rituximab. Transplantation 76:730–731
Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I (2005) ABO incompatible kidney transplantation without splenectomy, using antigen-specific immunoabsorption and Rituximab. Am J Transplant 5:145–148
Viret C, Janeway CA Jr (1999) MHC and T cell development. Rev Immunogenet 1:91–104
Wakayama T, Tabar V, Rodriguez I, Perry AC, Studer L, Mombaerts P (2001) Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292:740–743
Wang L, Duan E, Sung LY, Jeong BS, Yang X, Tian XC (2005) Generation and characterization of pluripotent stem cells from cloned bovine embryos. Biol Reprod 73:149–155
Wekerle T, Sykes M (2001) Mixed chimerism and transplantation tolerance. Annu Rev Med 52:353–370
Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, Swenson KG, Zhao G, Sykes M (1999) Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 68:1348–1355
Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M (2000) Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6:464–469
Xu C, Police S, Rao N, Carpenter MK (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91:501–508
Zhan X, Dravid G, Ye Z, Hammond H, Shamblott M, Gearhart J, Cheng L (2004) Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 364:163–171
Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129–1133
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grinnemo, KH., Sylvén, C., Hovatta, O. et al. Immunogenicity of human embryonic stem cells. Cell Tissue Res 331, 67–78 (2008). https://doi.org/10.1007/s00441-007-0486-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-007-0486-3